A former White House public health adviser admits she limited RFK Jr.’s access to officials. The revelation raises questions about transparency in vaccine policy debates.
Posts tagged as “vaccine safety”
A report alleges officials ignored warning signals tied to COVID vaccines and restricted data access. The claims raise questions about transparency and oversight.
A new report alleges FDA officials rejected a more advanced method for detecting COVID-19 vaccine safety signals. Emails suggest concerns over public perception influenced the decision.
A sharp divide emerges between experts over vaccine safety, efficacy, and research practices. The debate highlights conflicting interpretations of data and public health outcomes.
A new book examines how COVID-era messaging and censorship influenced public understanding of the pandemic. It raises questions about institutional coordination and transparency.
A recent study examines links between mRNA COVID vaccines and heart inflammation in teenagers. Findings raise new questions about risks and long-term monitoring.
Newly highlighted CDC V-Safe data is fueling debate over vaccine safety and transparency. Critics argue the findings raise concerns about reported side effects and public trust.
A CDC safety signal raised questions about a possible stroke risk following Pfizer vaccination in older adults. The issue has fueled debate over transparency and public health messaging.
Pfizer plans to seek FDA approval for its Lyme disease vaccine despite failing key trial benchmarks. Experts raise concerns over efficacy and safety data.
Researchers published a major review outlining biological mechanisms by which aluminum adjuvants in vaccines may contribute to autism in genetically susceptible children.
Children’s Health Defense (CHD) and five other plaintiffs today accused the American Academy of Pediatrics of running a decades-long racketeering scheme to defraud American families…
Vaccine industry leaders are blaming Health Secretary Robert F. Kennedy Jr. for falling sales, stock declines, and stalled investment in new vaccines. Executives say increased scrutiny of vaccine safety has disrupted long-standing approval and rollout expectations.
A newly published case study links a tetanus-diphtheria booster to the onset of a rare autoimmune blood disorder in a previously healthy adult. Researchers say the case highlights major gaps in vaccine safety research and post-market surveillance.
U.S. Health Secretary Robert F. Kennedy Jr. has removed multiple members of the federal commission overseeing the Vaccine Injury Compensation Program, signaling a push to reform what he has called a broken system. The move could lead to major changes in how vaccine injury claims are reviewed, debated, and compensated.
A new laboratory analysis found residual DNA fragments in Pfizer and Moderna mRNA COVID-19 vaccines that standard regulatory tests fail to detect. Researchers warn current testing methods may underestimate DNA contamination by more than 100-fold.
Major cancer journal confirms global turbo cancer safety signal as criminal cyberattacks possibly linked to PubPeer disrupt access to the study. By Nicolas Hulscher, MPH…
The FDA says it has no plans to add a black box warning to COVID-19 vaccines despite internal data linking the shots to reported deaths, including children. Critics argue the refusal undermines transparency and ignores documented harm tied to the injections.
FDA leadership has declined to add a black box warning to COVID-19 mRNA injections despite a formal recommendation from its own safety division. Critics argue the decision ignores mounting peer-reviewed evidence of irreversible cardiac injury and institutional capture.